These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9403262)

  • 41. A study to assess the effects of a new Betadine cream formulation compared to a standard topical treatment regimen for burns.
    de Kock M; van der Merwe AE
    Burns Incl Therm Inj; 1987 Feb; 13(1):69-74. PubMed ID: 3828858
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antiseptic effect of povidone-iodine solution on abdominal skin during surgery and on thyroid-gland-related substances.
    Shindo K
    Dermatology; 1997; 195 Suppl 2():78-84. PubMed ID: 9403261
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Early topical treatment with povidone-iodine ointment reduces, and sometimes prevents, skin damage following heat stimulus.
    Wormser U
    Burns; 1998 Jun; 24(4):383. PubMed ID: 9688207
    [No Abstract]   [Full Text] [Related]  

  • 44. May intraperitoneal irrigation with Betadine improve cesarean delivery outcomes? Results of a 6 years' single centre experience.
    Marino R; Capriglione S; Morosetti G; Di Angelo Antonio S; Miranda A; Pazzola M; Lopez S; Patrizi L; Angioli R; Stella P
    J Matern Fetal Neonatal Med; 2018 Mar; 31(5):670-676. PubMed ID: 28274149
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Experiences with the use of povidone-iodine-containing local therapeutics in dermatological surgery and in the treatment of burns: testing for allergic sensitization in postsurgery patients.
    Juhász I
    Dermatology; 2002; 204 Suppl 1():52-8. PubMed ID: 12011522
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Therapeutic efficacy of povidone-iodine (Betadine) and dichloroxylenol (Septocid) in Holstein cows affected with endometritis and/or cervicitis.
    Koujan A; Eissa HM; Hussein MA; Ayoub MM; Afiefy MM
    Acta Vet Hung; 1996; 44(1):111-9. PubMed ID: 8826706
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glycyrrhizin gel as a vehicle for idoxuridine--I. Clinical investigations.
    Segal R; Pisanty S
    J Clin Pharm Ther; 1987 Jun; 12(3):165-71. PubMed ID: 3611213
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinical significance of betadine vaginal suppository treatment in pregnancy].
    Gimes G; Péter F
    Acta Pharm Hung; 1997 Nov; 67(6):249-53. PubMed ID: 9480620
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oral antivirals for the acute treatment of recurrent herpes labialis.
    Jensen LA; Hoehns JD; Squires CL
    Ann Pharmacother; 2004 Apr; 38(4):705-9. PubMed ID: 14966254
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A study of the clinical activity of a gel combining monocaprin and doxycycline: a novel treatment for herpes labialis.
    Skulason S; Holbrook WP; Thormar H; Gunnarsson GB; Kristmundsdottir T
    J Oral Pathol Med; 2012 Jan; 41(1):61-7. PubMed ID: 21535163
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of Cadexomer Iodine in the Treatment of Chronic Ulcers: A Randomized, Multicenter, Controlled Trial.
    Raju R; Kethavath SN; Sangavarapu SM; Kanjarla P
    Wounds; 2019 Mar; 31(3):85-90. PubMed ID: 30720444
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Herpes Labialis: A New Possibility for Topical Treatment with Well-Elucidated Drugs.
    Silva-Alvarez AF; de Carvalho ACW; Benassi-Zanqueta É; Oliveira TZ; Fonseca DP; Ferreira MP; Vicentini FTMC; Ueda-Nakamura T; Pedrazzi V; de Freitas O
    J Pharm Sci; 2021 Oct; 110(10):3450-3456. PubMed ID: 34197838
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Famciclovir for cutaneous herpesvirus infections: an update and review of new single-day dosing indications.
    Chacko M; Weinberg JM
    Cutis; 2007 Jul; 80(1):77-81. PubMed ID: 17725069
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: A multicenter, randomized, placebo-controlled trial.
    Sacks SL; Thisted RA; Jones TM; Barbarash RA; Mikolich DJ; Ruoff GE; Jorizzo JL; Gunnill LB; Katz DH; Khalil MH; Morrow PR; Yakatan GJ; Pope LE; Berg JE;
    J Am Acad Dermatol; 2001 Aug; 45(2):222-30. PubMed ID: 11464183
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Topical resiquimod 0.01% gel decreases herpes simplex virus type 2 genital shedding: a randomized, controlled trial.
    Mark KE; Corey L; Meng TC; Magaret AS; Huang ML; Selke S; Slade HB; Tyring SK; Warren T; Sacks SL; Leone P; Bergland VA; Wald A
    J Infect Dis; 2007 May; 195(9):1324-31. PubMed ID: 17397003
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antiseptic effects at injection sites.
    Arata T; Kamitani M; Miyai T; Ito M
    Dermatology; 1997; 195 Suppl 2():107-10. PubMed ID: 9403267
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Evaluation of therapeutic effects of moist burn ointment and betadine ointment in treatment of severe burn].
    Zheng S; Li T; Chen W
    Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1996 Nov; 12(6):437-9. PubMed ID: 9387435
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ineffectiveness of topical adenine arabinoside 5'-monophosphate in the treatment of recurrent herpes simplex labialis.
    Spruance SL; Crumpacker CS; Haines H; Bader C; Mehr K; MacCalman J; Schnipper LE; Klauber MR; Overall JC
    N Engl J Med; 1979 May; 300(21):1180-4. PubMed ID: 86158
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral and perioral herpes simplex virus type 1 (HSV-1) infection: review of its management.
    Arduino PG; Porter SR
    Oral Dis; 2006 May; 12(3):254-70. PubMed ID: 16700734
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical Inquiry: which drugs are most effective for recurrent herpes labialis?
    Tubridy E; Kelsberg G; St Anna L
    J Fam Pract; 2014 Feb; 63(2):104-5. PubMed ID: 24527475
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.